News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
145,263 Results
Type
Article (4621)
Company Profile (44)
Press Release (140598)
Multimedia
Podcasts (3)
Webinars (1)
Section
Business (50977)
Career Advice (147)
Deals (10110)
Drug Delivery (16)
Drug Development (17634)
Employer Resources (15)
FDA (3875)
Job Trends (4116)
News (81586)
Policy (5954)
Tag
Academia (419)
Academic (1)
Accelerated approval (1)
Adcomms (1)
Allergies (27)
Alliances (6759)
ALS (23)
Alzheimer's disease (324)
Antibody-drug conjugate (ADC) (23)
Approvals (3918)
Artificial intelligence (38)
Autoimmune disease (6)
Automation (3)
Bankruptcy (50)
Best Places to Work (3778)
BIOSECURE Act (3)
Biosimilars (33)
Biotechnology (14)
Bladder cancer (37)
Brain cancer (12)
Breast cancer (87)
Cancer (650)
Cardiovascular disease (51)
Career advice (124)
Career pathing (3)
CAR-T (26)
Cell therapy (84)
Cervical cancer (3)
Clinical research (15364)
Collaboration (148)
Company closure (1)
Compensation (60)
Complete response letters (4)
COVID-19 (474)
CRISPR (11)
C-suite (20)
Cystic fibrosis (15)
Data (789)
Decentralized trials (2)
Depression (6)
Diabetes (60)
Diagnostics (1665)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (28)
Drug pricing (11)
Drug shortages (2)
Duchenne muscular dystrophy (28)
Earnings (38696)
Editorial (8)
Employer branding (1)
Employer resources (14)
Events (20024)
Executive appointments (75)
FDA (4308)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (126)
Gene editing (21)
Generative AI (4)
Gene therapy (56)
GLP-1 (132)
Government (742)
Grass and pollen (1)
Guidances (110)
Healthcare (4664)
Huntington's disease (10)
IgA nephropathy (4)
Immunology and inflammation (26)
Indications (7)
Infectious disease (514)
Inflammatory bowel disease (29)
Influenza (13)
Intellectual property (21)
Interviews (16)
IPO (6529)
IRA (3)
Job creations (570)
Job search strategy (112)
Kidney cancer (5)
Labor market (5)
Layoffs (79)
Leadership (1)
Legal (1221)
Liver cancer (19)
Lung cancer (106)
Lymphoma (52)
Management (9)
Manufacturing (52)
MASH (35)
Medical device (3107)
Medtech (3107)
Mergers & acquisitions (3740)
Metabolic disorders (155)
Multiple sclerosis (26)
NASH (8)
Neurodegenerative disease (21)
Neuropsychiatric disorders (4)
Neuroscience (466)
NextGen: Class of 2025 (1372)
Non-profit (1070)
Now hiring (1)
Obesity (64)
Opinion (21)
Ovarian cancer (16)
Pain (21)
Pancreatic cancer (25)
Parkinson's disease (46)
Partnered (6)
Patents (42)
Patient recruitment (13)
Peanut (14)
People (5315)
Pharmaceutical (16)
Pharmacy benefit managers (10)
Phase I (3799)
Phase II (6230)
Phase III (6291)
Pipeline (687)
Policy (22)
Postmarket research (716)
Preclinical (1239)
Press Release (8)
Prostate cancer (37)
Psychedelics (3)
Radiopharmaceuticals (54)
Rare diseases (82)
Real estate (953)
Recruiting (4)
Regulatory (4478)
Reports (7)
Research institute (421)
Resumes & cover letters (23)
Rett syndrome (1)
RSV (16)
Schizophrenia (18)
Series A (18)
Series B (16)
Service/supplier (3)
Sickle cell disease (16)
Special edition (7)
Spinal muscular atrophy (27)
Sponsored (7)
Startups (404)
Stomach cancer (3)
Supply chain (9)
Tariffs (11)
The Weekly (3)
Vaccines (154)
Venture capitalists (7)
Weight loss (32)
Women's health (4)
Date
Last 7 days (370)
Last 30 days (901)
Last 365 days (8880)
2025 (3395)
2024 (9040)
2023 (10283)
2022 (11699)
2021 (13647)
2020 (12697)
2019 (10987)
2018 (8218)
2017 (6919)
2016 (5747)
2015 (7771)
2014 (5284)
2013 (3907)
2012 (4391)
2011 (5080)
2010 (4232)
Location
Africa (110)
Alabama (11)
Alaska (1)
Arizona (36)
Arkansas (3)
Asia (8422)
Australia (1140)
California (1690)
Canada (434)
China (111)
Colorado (61)
Connecticut (75)
Delaware (69)
Europe (18654)
Florida (251)
Georgia (59)
Idaho (15)
Illinois (125)
India (5)
Indiana (88)
Iowa (4)
Japan (51)
Kansas (36)
Kentucky (4)
Louisiana (6)
Maine (19)
Maryland (207)
Massachusetts (1265)
Michigan (62)
Minnesota (106)
Mississippi (1)
Missouri (27)
Montana (2)
Nebraska (2)
Nevada (17)
New Hampshire (13)
New Jersey (691)
New Mexico (4)
New York (499)
North Carolina (271)
North Dakota (1)
Northern California (784)
Ohio (38)
Oregon (5)
Pennsylvania (349)
Rhode Island (9)
South America (165)
South Carolina (2)
Southern California (667)
Tennessee (24)
Texas (214)
United States (6479)
Utah (117)
Virginia (35)
Washington D.C. (22)
Washington State (130)
Wisconsin (17)
145,263 Results for "80".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Sanofi Cuts Off Antibody Partner, Forcing 80% Headcount Reduction at IGM
After losing its powerhouse partner, IGM Biosciences closed “most” of its labs and offices and initiated a strategic review of potential strategic alternatives and options for the business.
May 9, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Tempest Cuts 80% of Staff While Considering Strategic Alternatives
California-based Tempest Therapeutics is laying off 21 of its 26 full-time employees. The cuts come while the biotech is exploring strategic alternatives, including a merger or acquisition, as it tries to move its investigational PPARα antagonist into late-stage development.
April 21, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Bruker Introduces Innovative Fourier 80 Multinuclear Benchtop FT-NMR
April 7, 2025
·
3 min read
Press Releases
80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR Annual meeting
April 29, 2025
·
5 min read
Press Releases
Samsung Bioepis’ Second Quarter 2025 Biosimilar Market Report Highlights US Debut of Ustekinumab Biosimilars with WAC discounts over 80% and Regulatory Streamlining
April 25, 2025
·
4 min read
Press Releases
Eyenovia Announces 1-for-80 Reverse Stock Split
January 28, 2025
·
5 min read
Press Releases
Johnson & Johnson’s TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC
April 28, 2025
·
10 min read
Press Releases
U.S. Medical Device Outsourcing Market Size to Reach USD 94.80 Bn By 2034
February 25, 2025
·
1 min read
Press Releases
Cell Analysis Market Size to Hit USD 80.14 Billion by 2034
January 22, 2025
·
1 min read
Press Releases
Candel Therapeutics Announces $80 Million Proposed Public Offering
December 13, 2024
·
5 min read
1 of 14,527
Next
